A Phase 2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) for Initial Therapy of Chronic Lymphocytic Leukemia
NOT ENROLLING
Trial ID:
NCT03580928 Protocol # :
18-226
Phase
II
Disease Sites
Lymphoid Leukemia
Principal Investigator
Davids, Matthew, S
Site Investigator
Arnason, Jon
Site Research Nurses
Aiken, Haley
Aspinwall, Sheridan
Babcock, Elise
Beaver, Rachel, Maureen
Brennan, Lisa
Bresnahan, Caitlin
Bright, Susan
Burke, Candace
Chung, Anita
Coleman, Kimberly, C.
Davis, Jaynie
Francoeur, Karen
Green, Mallory
Kats, Vanessa
Kilcommons, Marykate
Knudsen, Elisabeth
Logan, Emma, Kristen
Maciejewski, Ashley, Taylor
Marzullo, Tess, V.
Normilus, Samantha
Nutter, Meredith, Elise
Patterson, Victoria
Re, Sandra
Serino-Cipoletta, Jessica
Silva, Wendy, Ann
Smith, Caitlin
Tichon, Jennifer
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #18-226
18-226